Copyright
©The Author(s) 2024.
World J Clin Cases. May 6, 2024; 12(13): 2218-2230
Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2218
Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2218
Figure 1 Literature screening flowchart.
Figure 2 Risk of bias assessment of included studies.
Figure 3 Meta-analysis results for the clinical efficacy rate.
Figure 4 Meta-analysis results for N-terminal pro-B-type natriuretic peptide and brain natriuretic peptide.
A: N-terminal pro-B-type natriuretic peptide; B: Brain natriuretic peptide.
Figure 5 Meta-analysis results for cardiac function.
A: Left ventricular ejection fraction; B: Left ventricular end-diastolic diameter; C: Left ventricular end-systolic diameter.
Figure 6 Meta-analysis results for 6-min walk test.
Figure 7 Meta-analysis results for readmission rate.
Figure 8 Meta-analysis results for adverse events.
Figure 9 Egger's test for publication bias.
- Citation: Lu SH, Yu YF, Dai SS, Hu YQ, Liu JH. Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis. World J Clin Cases 2024; 12(13): 2218-2230
- URL: https://www.wjgnet.com/2307-8960/full/v12/i13/2218.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i13.2218